✦ LIBER ✦

Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions

✍ Scribed by Elizabeth A. Hahn; Kimberly A. Webster; David Cella; Diane L. Fairclough

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 177 KB
Volume: 17
Category: Article
ISSN: 0277-6715
DOI: 10.1002/(sici)1097-0258(19980315/15)17:5/7<547::aid-sim802>3.0.co;2-f

No coin nor oath required. For personal study only.

✦ Synopsis

Incorporation of quality of life (QOL) investigation into Eastern Cooperative Oncology Group (ECOG) multi-centre clinical trials has led to innovative strategies for protocol design and high quality data collection. A scientific advisory committee reviews protocol design components, measurement selection, timing of assessments and compliance issues. Extensive educational programmes provide information about the scientific and clinical relevance of QOL protocols, as well as practical strategies for data collection and management. Compliance with QOL data collection standards is prospectively monitored and evaluated. Preliminary results from eight ECOG-run protocols found overall compliance to be approximately 85 per cent (94 per cent at baseline and 73 per cent during treatment). Selected patient and institutional factors were evaluated for their association with compliance.

📜 SIMILAR VOLUMES

Missing quality of life data in cancer c

Missing quality of life data in cancer clinical trials: serious problems and challenges

✍ Jürg Bernhard; David F. Cella; Alan S. Coates; Lesley Fallowfield; Patricia A. G 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

Measurement of quality of life (QOL) in cancer clinical trials has increased in recent years as more groups realize the importance of such endpoints. A key problem has been missing data. Some QOL data may unavoidably be missing, as for example when patients are too ill to complete forms. Other impor

Why are missing quality of life data a p

Why are missing quality of life data a problem in clinical trials of cancer therapy?

✍ Diane L. Fairclough; Harriet F. Peterson; Victor Chang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

Assessment of health related quality of life has become an important endpoint in many cancer clinical trials. Because the participants of these trials often experience disease and treatment related morbidity and mortality, non-random missing assessments are inevitable. Examples are presented from se

Statistical analysis of quality of life

Statistical analysis of quality of life with missing data in cancer clinical trials

✍ Andrea B. Troxel; Diane L. Fairclough; Desmond Curran; Elizabeth A. Hahn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials, especially those related to missing data. We describe different types of missing data mechanisms, and discuss ways of assessing and testing missing data mechanisms. A section on presentation of stud

Evaluation of pathology review of malign

Evaluation of pathology review of malignant lymphomas and Hodgkin's disease in cooperative clinical trials: The eastern cooperative oncology group experience

✍ Barbara C. Wolf; Kennedy W. Gilchrist; Risa B. Mann; Richard S. Neiman 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 1 views

Quality of life assessment in Internatio

Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data

✍ Jürg Bernhard; Harriet F. Peterson; Alan S. Coates; Heidi Gusset; Mary Isley; Ri 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

We report on our experience of quality of life (QL) assessment in adjuvant clinical trials of the International Breast Cancer Study Group (IBCSG), with special emphasis on cultural and logistical aspects of international organization that are unique to this group. Data are presented regarding submis

Practical issues in quality of life asse

Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer Research

✍ Jürg Bernhard; Heidi Gusset; Christoph Hürny 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

Quality of life (QOL) assessment has become an integrated part in some advanced disease trials and to a lesser extent in early disease trials conducted by the Swiss Group for Clinical Cancer Research (SAKK). In general, the concept of QOL endpoints and the additional work of collecting these data is